NCT00198380 - Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions

Pneumonic-type Adenocarcinoma (P-ADC)Lung Adenocarcinoma With Bronchiolo-alveolar Feature

Interventions

DRUG

Gefitinib

Gefitinib 250 mg/day, until progression or severe toxicity

Trial Locations (11)

Centre F. Baclesse, Caen

CHU - Pneumologie, Caen

CHU Besancon - Pneumologie, Besançon

CHU Grenoble - pneumologie, Grenoble

CHU Saint-Etienne Pneumologie, Saint-Etienne

CHU Lyautey - Pneumologie, Strasbourg

HCL - Croix-Rousse, Lyon

HCL - Lyon Sud (Pneumologie), Pierre-Bénite

APHP - Saint-Antoine - pneumologie, Paris

Hopital Tenon - Pneumologie, Paris

APHP - CHU Avicenne - Oncologie Medicale, Bobigny